https://www.selleckchem.com/pr....oducts/dabrafenib-gs
Whether the association between type 2 diabetes (T2D) and cancer is causal remains controversial. The goal of this work is to assess the robustness of the observational associations between T2D and cancer to unmeasured confounding. PubMed, Web of Science, and the Cochrane library were systematically searched on 10 January 2019 for observational studies investigating associations between T2D and cancer incidence or mortality. Cohort-level relative risk (RR) was extracted. RRs were combined in random-effects meta-analyses an
Aimer
Commentaire
Partagez
